Insiders · Profile

Sermon Charles

General Counsel at Mereo BioPharma. Filing since 25 Jun 2024. CIK 0001687318

Company
Date
Role
Action
Shares
Amount
Of holding
13 Sep 2024
General Counsel
Sold at will
20,946
$88.41K
8.7%
12 Sep 2024
General Counsel
Sold at will
9,980
$44.64K
4.0%
26 Jun 2024
General Counsel
Sold at will
32,187
$109.22K
14.9%
25 Jun 2024
General Counsel
Sold at will
14,202
$52.46K
6.2%
4 decisions on file.